Gene · 4948
Papers2,190
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,190
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genome-wide DNA methylation of lesional and peri-lesional skin in vitiligo: a comparative and integrated analysis of multi-omics in Chinese population. | Hum Genet | 2024 | 38182908 | PubTator, text mining | PubMed |
| Multi-ancestry genome-wide meta-analysis identifies novel basal cell carcinoma loci and shared genetic effects with squamous cell carcinoma. | Commun Biol | 2024 | 38182794 | PubTator, text mining | PubMed |
| Genetic landscape of forensic DNA phenotyping markers among Mediterranean populations. | Forensic Sci Int | 2024 | 38128201 | PubTator, text mining | PubMed |
| Branched-Chain Amino Acid Accumulation Fuels the Senescence-Associated Secretory Phenotype. | Adv Sci (Weinh) | 2024 | 37964763 | PubTator, text mining | PubMed |
| Unveiling genetics of non-syndromic albinism using whole exome sequencing: A comprehensive study of TYR, TYRP1, OCA2 and MC1R genes in 17 families. | Gene | 2024 | 37956964 | PubTator, text mining | PubMed |
| Novel compound heterozygous mutations in OCA2 gene were identified in a Chinese family with oculocutaneous albinism. | Mol Genet Genomic Med | 2024 | 37882226 | PubTator, text mining | PubMed |
| Proteomics on malignant pleural effusions reveals ERα loss in metastatic breast cancer associates with SGK1-NDRG1 deregulation. | Mol Oncol | 2024 | 37854018 | PubTator, text mining | PubMed |
| Mechanism of PARP inhibitor resistance and potential overcoming strategies. | Genes Dis | 2024 | 37588193 | PubTator, text mining | PubMed |
| Multigenerational diabetes mellitus. | Front Endocrinol (Lausanne) | 2023 | 38288471 | PubTator, text mining | PubMed |
| Disulfidptosis-related classification patterns and tumor microenvironment characterization in skin cutaneous melanoma. | Melanoma Manag | 2023 | 38230203 | PubTator, text mining | PubMed |
| Serological surveillance of GI norovirus reveals persistence of blockade antibody in a Jidong community-based prospective cohort, 2014-2018. | Front Cell Infect Microbiol | 2023 | 38188632 | PubTator, text mining | PubMed |
| Molecular biology of canine parainfluenza virus V protein and its potential applications in tumor immunotherapy. | Front Microbiol | 2023 | 38173672 | PubTator, text mining | PubMed |
| A 14-year-old male patient with diagnosis of Prader-Willi syndrome in Ethiopia: a case report. | J Med Case Rep | 2023 | 38143282 | PubTator, text mining | PubMed |
| Patterns of Gene Expression, Splicing, and Allele-Specific Expression Vary among Macular Tissues and Clinical Stages of Age-Related Macular Degeneration. | Cells | 2023 | 38067097 | PubTator, text mining | PubMed |
| Genomic analysis of a Palestinian family with inherited cancer syndrome: a next-generation sequencing study. | Front Genet | 2023 | 38028607 | PubTator, text mining | PubMed |
| Problems with studying directional natural selection in humans. | Vavilovskii Zhurnal Genet Selektsii | 2023 | 38023807 | PubTator, text mining | PubMed |
| Antiproliferative and Cytotoxic Properties of Propynoyl Betulin Derivatives against Human Ovarian Cancer Cells: In Vitro Studies. | Int J Mol Sci | 2023 | 38003677 | PubTator, text mining | PubMed |
| NGS Custom Panel Implementation in Patients with Non-Syndromic Autism Spectrum Disorders in the Clinical Routine of a Tertiary Hospital. | Genes (Basel) | 2023 | 38003033 | PubTator, text mining | PubMed |
| Immunotherapy and Its Timing in Advanced Basal Cell Carcinoma Treatment. | Dermatol Pract Concept | 2023 | 37992360 | PubTator, text mining | PubMed |
| Progress in the study of FOXO3a interacting with microRNA to regulate tumourigenesis development. | Front Oncol | 2023 | 37965449 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4948/papers?page=6